<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Abbott Laboratories News</title>
<link>http://www.inboxrobot.com/news/abbott-laboratories</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>Democrats line up to challenge Ryan</title>
<link>http://www.inboxrobot.com/news.php?fid=186830001</link>
<pubDate>6 Sep 2008 18:36 GMT</pubDate>
<description>
...  business administration from Northwestern University in Chicago while working as a third-shift supervisor for Abbott Laboratories. People said, Marge, you cant do that. I said watch me. Just like in  ...
</description>
</item><item>
<title>FDA orders stronger warnings for drugs</title>
<link>http://www.inboxrobot.com/news.php?fid=186794837</link>
<pubDate>6 Sep 2008 05:57 GMT</pubDate>
<description>
...  each. Cimzia is newer and less widely used. Humira is made by North Chicago-based Abbott Laboratories Inc. 1. Comments are not edited and don&apos;t represent the views of the Daily  ...
</description>
</item><item>
<title>Abbott sells spine business</title>
<link>http://www.inboxrobot.com/news.php?fid=186794824</link>
<pubDate>6 Sep 2008 05:57 GMT</pubDate>
<description>
... Zimmer Holdings Inc. said it agreed to buy the spine business of Abbott Laboratories for $360 million in cash. The boards of both companies have approved the transaction,  ...
</description>
</item><item>
<title>Zimmer to Acquire Abbott&apos;s Spine Unit</title>
<link>http://www.inboxrobot.com/news.php?fid=186762203</link>
<pubDate>6 Sep 2008 00:49 GMT</pubDate>
<description>
...  Spine Unit Sept. 8, 2008 | Vol. 5 No. 175 Zimmer Holdings will acquire Abbott Labs&apos; spinal business for roughly $360 million in cash. The boards of directors of both  ...
</description>
</item><item>
<title>FDA-Requested Study Leads Abbott to Update Norvir Label</title>
<link>http://www.inboxrobot.com/news.php?fid=186762200</link>
<pubDate>6 Sep 2008 00:49 GMT</pubDate>
<description>
...  2008 | Vol. 40 No. 35 FDA-Requested Study Leads Abbott to Update Norvir Label Abbott Laboratories has updated the label for its protease inhibitor Norvir to include a new precaution  ...
</description>
</item><item>
<title>Zimmer Fortifies Its Spine</title>
<link>http://www.inboxrobot.com/news.php?fid=186754634</link>
<pubDate>5 Sep 2008 23:28 GMT</pubDate>
<description>
...  little more spine as it competes with Medtronic . The medical-device maker is buying Abbott Labs &apos; spine business for $360 million in cash. The division, which registered $109 million  ...
</description>
</item><item>
<title>Arthritis Drugs Raise Risk of Fatal Infections</title>
<link>http://www.inboxrobot.com/news.php?fid=186714698</link>
<pubDate>5 Sep 2008 19:41 GMT</pubDate>
<description>
...  Cimzia is newer and less widely used. Humira is sold by North Chicago, Ill.-based Abbott Laboratories Inc; Cimzia by Belgium-based UCB; Enbrel by Thousand Oaks, Calif.-based Amgen Inc. and Madison,  ...
</description>
</item><item>
<title>Abbott to Present at Bank of America 38th Annual Investment Conference</title>
<link>http://www.inboxrobot.com/news.php?fid=186710420</link>
<pubDate>5 Sep 2008 19:06 GMT</pubDate>
<description>
... ABBOTT PARK, Ill., Sept. 5 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) will present at the Bank of America 38th Annual Investment Conference on Monday, Sept.  ...
</description>
</item><item>
<title>4C Controls Announces Acquisition of UAE Security &amp; Surveillance Enterprise</title>
<link>http://www.inboxrobot.com/news.php?fid=186709200</link>
<pubDate>5 Sep 2008 18:59 GMT</pubDate>
<description>
...  International -- Reuters, Lucent Technologies, British American Tobacco -- Estee Lauder, Kinko&apos;s Middle East, Abbott Laboratories -- Dubai Petroleum, Saatchi &amp; Saatchi, Shell Middle East -- Bechtel International, ETISALAT, Ford  ...
</description>
</item><item>
<title>Abbott to Present at UBS &apos;Best of Americas&apos; Investment Conference</title>
<link>http://www.inboxrobot.com/news.php?fid=186706066</link>
<pubDate>5 Sep 2008 18:53 GMT</pubDate>
<description>
...  UBS &apos;Best of Americas&apos; Investment Conference ABBOTT PARK, Ill., Sept. 5 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) will present at the UBS &quot;Best of Americas&quot; Investment Conference on Friday, Sept. 12,  ...
</description>
</item><item>
<title>FDA orders label changes on four TNF blockers</title>
<link>http://www.inboxrobot.com/news.php?fid=186675772</link>
<pubDate>5 Sep 2008 15:33 GMT</pubDate>
<description>
...  of opportunistic fungal infections. The products in question are Johnson &amp; Johnson/Schering-Plough&apos;s Remicade (infliximab), Abbott Laboratories&apos; Humira (adalimumab), Amgen and Wyeth&apos;s Enbrel (etanercept) and UCB&apos;s Cimzia (certolizumab pegol). The FDA  ...
</description>
</item><item>
<title>Abbott recognized on Dow Jones sustainability index ...</title>
<link>http://www.inboxrobot.com/news.php?fid=186671519</link>
<pubDate>5 Sep 2008 15:16 GMT</pubDate>
<description>
...  read or download the company&apos;s 2007 global citizenship report, please visit About Abbott Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and  ...
</description>
</item><item>
<title>4 arthritis drugs must carry stronger warnings</title>
<link>http://www.inboxrobot.com/news.php?fid=186648908</link>
<pubDate>5 Sep 2008 13:05 GMT</pubDate>
<description>
...  Cimzia is newer and less widely used. Humira is made by North Chicago, Ill.-based Abbott Laboratories Inc; Cimzia by Belgium-based UCB; Enbrel by Thousand Oaks, Calif.-based Amgen Inc. and Madison,  ...
</description>
</item><item>
<title>FDA orders stronger warnings for 4 rheumatoid arthritis drugs</title>
<link>http://www.inboxrobot.com/news.php?fid=186645533</link>
<pubDate>5 Sep 2008 12:50 GMT</pubDate>
<description>
...  Cimzia is newer and less widely used. Humira is sold by North Chicago, Ill.-based Abbott Laboratories Inc; Cimzia by Belgium-based UCB; Enbrel by Thousand Oaks, Calif.-based Amgen Inc. and Madison,  ...
</description>
</item><item>
<title>Regional Report / Smead will sell European operations to insiders</title>
<link>http://www.inboxrobot.com/news.php?fid=186632814</link>
<pubDate>5 Sep 2008 06:37 GMT</pubDate>
<description>
...  Zimmer Holdings Inc. is paying $360 million to acquire the spinal products business of Abbott Laboratories  a deal that&apos;s intended to supplement Zimmer&apos;s existing spinal business, which is based  ...
</description>
</item></channel>
</rss>
